Please login to the form below

Not currently logged in

HPV vaccine

This page shows the latest HPV vaccine news and features for those working in and with pharma, biotech and healthcare.

GSK eyes follow-up HPV vaccine

GSK eyes follow-up HPV vaccine

Cervarix from the US market after finding it was not competitive against rival Merck &Co’s HPV vaccine. ... It also has a 9-valent HPV vaccine in a phase 2 clinical trial, which will help to protect individuals against diseases caused by nine types of

Latest news

More from news
Approximately 2 fully matching, plus 47 partially matching documents found.

Latest Intelligence

  • Immunisation politicised Immunisation politicised

    Reshaping the HPV vaccine in Austria. While swift in other European countries, implementation took several years in Austria. ... Many countries objected to the HPV vaccine yet the vaccine was introduced rather rapidly in most countries.

  • Country report: The healthcare market in Japan Country report: The healthcare market in Japan

    Diovan. valsartan. Novartis. Hypertension. 4. Cervarix. human papillomavirus (HPV) vaccine. GlaxoSmithKline. ... HPV. 5. Lipitor. atorvastatin. Pfizer. Cholesterol lowerer. IMS Health Japan (July to September 2011, Q3).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Understanding the "Big Picture"

    A good example of this “Risk-awareness thinking” would be the impact of the cervical cancer vaccine to address human papilloma virus (HPV). ... Unlike the majority of diseases which have an incidence population continuously contributing to the

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...